<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Biochem Res Int</journal-id><journal-id journal-id-type="iso-abbrev">Biochem Res Int</journal-id><journal-id journal-id-type="publisher-id">BRI</journal-id><journal-title-group><journal-title>Biochemistry Research International</journal-title></journal-title-group><issn pub-type="ppub">2090-2247</issn><issn pub-type="epub">2090-2255</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4736757</article-id><article-id pub-id-type="doi">10.1155/2016/2959414</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Silica Nanoparticles Effects on Blood Coagulation Proteins and Platelets</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Gryshchuk</surname><given-names>Volodymyr</given-names></name><xref ref-type="aff" rid="I1"><sup>1</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Galagan</surname><given-names>Natalya</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="I1"><sup>1</sup>ESC &#x0201c;Institute of Biology&#x0201d;, Kyiv National Taras Shevchenko University, 64/13 Volodymyrska Street, Kyiv 01601, Ukraine</aff><aff id="I2"><sup>2</sup>Chuiko Institute of Surface Chemistry, National Academy of Sciences of Ukraine, 17 General Naumov Street, Kyiv 03164, Ukraine</aff><author-notes><corresp id="cor1">*Volodymyr Gryshchuk: <email>gryshchukv@gmail.com</email></corresp><fn fn-type="other"><p>Academic Editor: Spyros S. Skandalis</p></fn></author-notes><pub-date pub-type="ppub"><year>2016</year></pub-date><pub-date pub-type="epub"><day>6</day><month>1</month><year>2016</year></pub-date><volume>2016</volume><elocation-id>2959414</elocation-id><history><date date-type="received"><day>30</day><month>10</month><year>2015</year></date><date date-type="accepted"><day>20</day><month>12</month><year>2015</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2016 V. Gryshchuk and N. Galagan.</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Interaction of nanoparticles with the blood coagulation is important prior to their using as the drug carriers or therapeutic agents. The aim of present work was studying of the primary effects of silica nanoparticles (SiNPs) on haemostasis<italic> in vitro</italic>. We studied the effect of SiNPs on blood coagulation directly estimating the activation of prothrombin and factor X and to verify any possible effect of SiNPs on human platelets. It was shown that SiNPs shortened coagulation time in APTT and PT tests and increased the activation of factor X induced by RVV possibly due to the sorption of intrinsic pathway factors on their surface. SiNPs inhibited the aggregation of platelet rich plasma induced by ADP but in the same time partially activated platelets as it was shown using flow cytometry. The possibility of SiNPs usage in nanomedicine is strongly dependant on their final concentration in bloodstream and the size of the particles that are used. However SiNPs are extremely promising as the haemostatic agents for preventing the blood loss after damage.</p></abstract></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>Interactions of nanoparticles with the blood coagulation system can be beneficial or adverse depending on the intended use of a nanomaterial. Nanoparticles can be engineered to be procoagulant or anticoagulant or to carry drugs to intervene in other pathological conditions in which coagulation is a concern [<xref rid="B1" ref-type="bibr">1</xref>]. Using of nanoparticles as the drug carriers is extremely promising and is of interest for scientists all over the world [<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B3" ref-type="bibr">3</xref>]. Nanoparticles can be designed as bacteriostatic agents as well [<xref rid="B4" ref-type="bibr">4</xref>]. Silica nanoparticles (SiNPs) have been shown as a promising alternative for biomedical applications [<xref rid="B5" ref-type="bibr">5</xref>] as a novel delivery in tumor research vector or tumor-targeting agent [<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>], and as the carriers of anticancer drugs [<xref rid="B8" ref-type="bibr">8</xref>, <xref rid="B9" ref-type="bibr">9</xref>]. For the use of SiNPs in bioengineering the study of their biocompatibility including cell toxicity [<xref rid="B10" ref-type="bibr">10</xref>], immunotoxicity [<xref rid="B11" ref-type="bibr">11</xref>], and genotoxic effects [<xref rid="B12" ref-type="bibr">12</xref>] is essential. The aim of present study was the estimation of the primary effects of SiNPs on haemostasis<italic> in vitro</italic>.</p></sec><sec id="sec2"><title>2. Materials and Methods</title><sec id="sec2.1"><title>2.1. Materials</title><sec id="sec2.1.1"><title>2.1.1. Chemicals</title><p>Chromogenic substrates S2238 (H-D-Phe-Pip-Arg-pNA) and S2236 (p-Glu-Pro-Arg-pNa) were purchased from BIOPHEN, and APTT-reagent was from Renam (Russia). Ecamulin purified from <italic>Echis multisquamatis</italic> venom was kindly donated by Dr. Korolova. Factor X activator from Russell's viper venom (RVV) and ADP were purchased from Sigma (US).</p></sec><sec id="sec2.1.2"><title>2.1.2. Silica Nanoparticles</title><p>Amorphous silica nanoparticles (SiNPs) A300 (Kalush, Ukraine) were pretreated at 400&#x000b0;C during 2 hours. The resulting material had the average space of surface as approximately 300&#x02009;m<sup>2</sup>/g and the size of particles ranged from 10 to 40&#x02009;nm [<xref rid="B13" ref-type="bibr">13</xref>].</p></sec></sec><sec id="sec2.2"><title>2.2. Methods</title><sec id="sec2.2.1"><title>2.2.1. Platelet Rich Plasma (PRP) and Blood Plasma Preparation</title><p>Venous blood of healthy volunteers who had not taken any medication for 7 days was collected into 38&#x02009;g/liter sodium citrate (9 parts blood to 1 part sodium citrate). PRP was isolated by centrifugation of blood at 160&#x02009;g for 20&#x02009;min at 23&#x000b0;C. For the preparation of platelet poor blood plasma PRP was spinned-down at 1500&#x02009;rpm during 30&#x02009;min [<xref rid="B14" ref-type="bibr">14</xref>].</p></sec><sec id="sec2.2.2"><title>2.2.2. Activated Partial Thromboplastin Time</title><p>Activated partial thromboplastin time (APTT) was performed according to the following procedure. 0,1&#x02009;mL of blood plasma was mixed with equal volume of APTT-reagent and incubated during 3 minutes at 37&#x000b0;C. Then the coagulation was initiated by adding of 0,1&#x02009;mL of 0.025&#x02009;M solution of CaCl<sub>2</sub>. Clotting time was monitored by the Coagulometer Solar CGL-2410 (Belorussia) [<xref rid="B15" ref-type="bibr">15</xref>].</p></sec><sec id="sec2.2.3"><title>2.2.3. Amidase Activity Assay</title><p>Hydrolysis of chromogenic substrates (S2238, H-D-Phe-Pip-Arg-pNA, S2765, Z-D-Arg-Gly-Arg-pNA) under the influence of silica nanoparticles (SiNPs) was studied using the reader (Thermo-Scientific), E405&#x02013;E492. The analysis was done in 0.05&#x02009;M Tris-HCl buffer of pH 7.4 solution, 37&#x000b0;&#x00421;. Chromogenic substrates were taken in the final concentration 30&#x02009;mM. The final concentration of SiNPs was 0.4&#x02009;mg/mL [<xref rid="B16" ref-type="bibr">16</xref>].</p></sec><sec id="sec2.2.4"><title>2.2.4. Fibrinogen Concentration Study</title><p>Fibrinogen concentration in the blood plasma was determined by the modified spectrophotometric method. Blood plasma (0.2&#x02009;mL) and PBS (1,7&#x02009;mL) were mixed in glass tube. Coagulation was initiated by the addition of 0.1&#x02009;mL of thrombin-like enzyme from the venom of<italic> Agkistrodon halys halys</italic> (1&#x02009;NIH/mL) that allowed avoiding fibrin cross-linking [<xref rid="B17" ref-type="bibr">17</xref>]. Mixture was incubated during 30&#x02009;min at 37&#x000b0;C. The fibrin clot was removed and resolved in 5&#x02009;mL of 1,5% acetic acid. The concentration of protein was measured using spectrophotometer SF-2000 (Russia) at 280&#x02009;nm (<italic>&#x003b5;</italic> = 1,5).</p></sec><sec id="sec2.2.5"><title>2.2.5. Platelet Aggregation Study</title><p>Platelet aggregation measuring was based on changes in the turbidity of platelet rich human plasma [<xref rid="B18" ref-type="bibr">18</xref>]. In typical experiment 0.4&#x02009;mL platelet rich plasma was incubated with 0.02&#x02009;mL of 0.025&#x02009;M CaCl<sub>2</sub> and ADP in final concentration 12.5&#x02009;<italic>&#x003bc;</italic>M at 37&#x000b0;C. Studied concentrations of SiNPs were 0,001 and 0,01&#x02009;mg/mL. Aggregation was detected for 10&#x02009;min using Aggregometer Solar AP2110.</p></sec><sec id="sec2.2.6"><title>2.2.6. Flow Cytometry</title><p>The shape and granulation of platelets after incubation with silica nanoparticles (SiNPs) versus platelets activated by thrombin were monitored on COULTER EPICS XL Flow Cytometer [<xref rid="B19" ref-type="bibr">19</xref>]. SiNPs (0,01&#x02009;mg/mL) were added to 1&#x02009;mL of washed platelets suspension and samples were incubated during 90&#x02009;min at 25&#x000b0;&#x00421;. Scattered and transmitted light was monitored for examining any changes of the platelets granulation and shape.</p></sec><sec id="sec2.2.7"><title>2.2.7. Statistic Data Analysis</title><p>Statistical data analysis was performed using Microsoft Excel. All assays were performed in series of three replicates and the data were fitted with standard errors using &#x0201c;Statistica 7.&#x0201d;</p></sec></sec></sec><sec id="sec3"><title>3. Results</title><sec id="sec3.1"><title>3.1. Proteins of Coagulation System with SiNPs</title><p>Amorphous silica nanoparticles (SiNPs) were precipitate in the PBS with the final concentration of stock solution 2&#x02009;mg/mL. All samples of SiNPs were mixed using Vortex<italic> ex temporo</italic>.</p><p>The basic coagulation tests APTT and PT were performed in the presence of SiNPs suspension in the final concentrations 0.2 and 0.4&#x02009;mg/mL. It was shown that SiNPs distinctly shortened coagulation time in both tests in concentration dependant manner (<xref ref-type="fig" rid="fig1">Figure 1</xref>). The effect was more evident for PT than for APTT.</p><p>Specific chromogenic substrates to prothrombin (S2238) and factor Xa (S2765) have been used to avoid the influence of fibrinogen sorption by SiNPs on the results of the tests.</p><p>We studied the effect of SiNPs on blood coagulation directly estimating the activation of prothrombin and factor X. Prothrombin was activated by the prothrombin activator from <italic>Echis multisquamatis</italic> venom (ecamulin). The resulting thrombin activity was detected by thrombin-specific chromogenic substrate S2238. It was shown that SiNPs taken in the concentration 0.4&#x02009;mg/mL did not affect the direct activation of prothrombin (<xref ref-type="fig" rid="fig2">Figure 2(a)</xref>).</p><p>Factor X was activated directly by RVV [<xref rid="B20" ref-type="bibr">20</xref>], activity of activated factor Xa estimated with specific chromogenic substrate S2765. It was shown that 0.4&#x02009;mg/mL of SiNPs inhibited the factor X activation (<xref ref-type="fig" rid="fig2">Figure 2(b)</xref>).</p><p>Thus we observed the inhibitory effect of SiNPs on blood coagulation that consisted in prolongation of time of coagulation initiated by thromboplastin and APTT-reagent as well as in the decreasing of the activation of factor Xa but not prothrombin.</p></sec><sec id="sec3.2"><title>3.2. Platelet Aggregation and Activation</title><p>Platelet aggregation in PRP induced by ADP was studied in the presence of absence of SiNPs at the final concentrations 0.001 and 0.01&#x02009;mg/mL. It was shown that these concentrations of SiNPs inhibited the rate and the speed of platelet aggregation (<xref ref-type="fig" rid="fig3">Figure 3</xref>). 0.001&#x02009;mg/mL of SiNPs decreased the aggregation rate twice and provoked huge disaggregation of platelets. These effects were even more evident when 0.01&#x02009;mg/mL of SiNPs was taken.</p><p>It is known that fibrinogen takes part in platelet aggregation by attracting the platelets to each other and to the newly formed clot. That is why we examined the ability of SiNPs to adsorb fibrinogen. It was shown that 1&#x02009;mg of SiNPs adsorbed 0.325&#x02009;mg of fibrinogen of blood plasma. Thus we can assume that the sorption of fibrinogen by SiNPs taken in the concentrations 0.001 and 0.01&#x02009;mg/mL could not inhibit platelet aggregation by removing the plasma fibrinogen.</p><p>The inhibitory effect on platelet aggregation could be explained by the action of studied agent on intracellular signaling or/and on binding of fibrinogen with its platelet receptor IIbIIIa [<xref rid="B21" ref-type="bibr">21</xref>]. So we have to examine whether the SiNPs could inhibit the platelet activation. For this aim the activation of platelets induced by thrombin was monitored using flow cytometry. The platelet shape and granularity were studied by direct and orthogonal light scattering [<xref rid="B18" ref-type="bibr">18</xref>].</p><p>To verify any possible effect of SiNPs on human platelets, PRP was analyzed by flow cytometry. Resting human platelets (a) were incubated with 0.001&#x02009;mg/mL of SiNPs (b) or 0.01&#x02009;mg/mL of SiNPs (d) during 5&#x02009;min. It was shown that the population of resting platelets decreased from 80 &#x000b1; 3% in control sample (a) to 67 &#x000b1; 4% and 52 &#x000b1; 2% in the samples with 0.001&#x02009;mg/mL of SiNPs (b) or 0.01&#x02009;mg/mL of SiNPs (d), respectively (<xref ref-type="fig" rid="fig4">Figure 4</xref>). In contrast, activation of platelets by thrombin (c) caused dramatic change to the platelets shape and granularity. Therefore we concluded that SiNPs were able to induce slight changes of shape and granularity of platelets that did not cause platelet aggregation but could affect platelet aggregation induced by ADP.</p></sec></sec><sec id="sec4"><title>4. Discussion</title><p>Interaction of silica with blood coagulation proteins is well studied area. Previously it was shown that the silica activity depends on the particle diameter and consists in the geometrical relations between the silica and the protein molecules [<xref rid="B22" ref-type="bibr">22</xref>]. The conformation of adsorbed proteins on the colloidal silica surfaces plays a role in modulating the amount of their function and cell binding [<xref rid="B23" ref-type="bibr">23</xref>]. It was shown that SiNPs effectively adsorbed fibronectin, fibrinogen, and so forth. Therefore SiNPs also modulate processes of cell adhesion by absorbing adhesion molecules [<xref rid="B24" ref-type="bibr">24</xref>] and also by direct incorporation in blood cells [<xref rid="B25" ref-type="bibr">25</xref>]. It was reported that SiNPs penetrated the platelet plasma membrane and stimulated a rapid and prolonged NO release, IIbIIIa activation, and finally the platelet aggregation [<xref rid="B25" ref-type="bibr">25</xref>].</p><p>In our study we showed the procoagulant effects of silica reported in several studies and used in combat gauze development [<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B27" ref-type="bibr">27</xref>] caused mainly by the action of SiNPs on factor Xa activation. Our previous findings reported in [<xref rid="B28" ref-type="bibr">28</xref>] showed that this activation did not occur when intrinsic coagulation factors (namely, XII and XI) were removed from the incubation volume. This data corresponds to the results of that showeing the sorption of factor XII on the surface of SiNPs that strongly depends on the size of the particles [<xref rid="B29" ref-type="bibr">29</xref>, <xref rid="B30" ref-type="bibr">30</xref>]. However, any of our experiments showed the direct coagulant action of SiNPs on unactivated blood plasma or the activating action of SiNPs on platelet aggregation. Despite this, studied SiNPs were able to change the shape and granularity of resting platelets studied by flow cytometry that corresponded to the data of other scientists that demonstrated incorporation of SiNPs in the living cells [<xref rid="B25" ref-type="bibr">25</xref>]. We can assume that small SiNPs from the studied samples (10&#x02009;nm) were incorporated into cells and activate them (as it was shown by Corbalan et al. [<xref rid="B25" ref-type="bibr">25</xref>]) but bigger nanoparticles (up to 40&#x02009;nm) that also were present in the samples inhibited platelet aggregation by absorbing fibrinogen [<xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B24" ref-type="bibr">24</xref>] that is sufficient for platelets aggregation [<xref rid="B21" ref-type="bibr">21</xref>].</p><p>Our findings also corresponded to the results obtained recently on<italic> in vivo</italic> models of SiNPs administration where systemic activation of coagulation cascade and platelets were shown [<xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B31" ref-type="bibr">31</xref>].</p></sec><sec id="sec5"><title>5. Conclusions</title><p>Amorphous SiNPs are able to increase the activation of coagulation cascade by adsorbing and stimulating of intrinsic pathway coagulation factors. This effect resulted in shortening of coagulation time in APTT and PT tests, as well as in the increasing of factor X activation by RVV in blood plasma but not in the sample with removed factors XI and XII. SiNPs did not induce platelet aggregation in PRP but changed the shape and granularity of resting platelets and inhibited their aggregation. The possibility of SiNPs usage in nanomedicine is strongly dependant on their final concentration in bloodstream and the size of the particles that are used. However, SiNPs are extremely promising as the haemostatic agents for preventing the blood loss after damage.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>SiNPs:</term><def><p>Silica nanoparticles</p></def></def-item><def-item><term>RVV:</term><def><p>
<italic> Russel vipera</italic> venom</p></def></def-item><def-item><term>PRP:</term><def><p>Platelet rich plasma</p></def></def-item><def-item><term>APTT:</term><def><p>Activated partial thromboplastin time</p></def></def-item><def-item><term>PT:</term><def><p>Prothrombin time.</p></def></def-item></def-list></glossary><sec sec-type="conflict"><title>Conflict of Interests</title><p>The authors declare that there is no conflict of interests regarding the publication of this paper.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ilinskaya</surname><given-names>A. N.</given-names></name><name><surname>Dobrovolskaia</surname><given-names>M. A.</given-names></name></person-group><article-title>Nanoparticles and the blood coagulation system. Part II: safety concerns</article-title><source><italic>Nanomedicine</italic></source><year>2013</year><volume>8</volume><issue>6</issue><fpage>969</fpage><lpage>981</lpage><pub-id pub-id-type="doi">10.2217/nnm.13.49</pub-id><pub-id pub-id-type="other">2-s2.0-84878691367</pub-id><pub-id pub-id-type="pmid">23730696</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>J.</given-names></name><name><surname>Liong</surname><given-names>M.</given-names></name><name><surname>Zink</surname><given-names>J. I.</given-names></name><name><surname>Tamanoi</surname><given-names>F.</given-names></name></person-group><article-title>Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs</article-title><source><italic>Small</italic></source><year>2007</year><volume>3</volume><issue>8</issue><fpage>1341</fpage><lpage>1346</lpage><pub-id pub-id-type="doi">10.1002/smll.200700005</pub-id><pub-id pub-id-type="other">2-s2.0-34547838187</pub-id><pub-id pub-id-type="pmid">17566138</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>K.</given-names></name></person-group><article-title>Controlled drug delivery systems: past forward and future back</article-title><source><italic>Journal of Controlled Release</italic></source><year>2014</year><volume>190</volume><fpage>3</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.jconrel.2014.03.054</pub-id><pub-id pub-id-type="other">2-s2.0-84906781463</pub-id><pub-id pub-id-type="pmid">24794901</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jamil</surname><given-names>B.</given-names></name><name><surname>Bokhari</surname><given-names>H.</given-names></name><name><surname>Imran</surname><given-names>M.</given-names></name></person-group><article-title>Mechanism of action: how nano-antimicrobials act?</article-title><source><italic>Current Drug Targets</italic></source><comment>In press</comment></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hao</surname><given-names>N.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Tang</surname><given-names>F.</given-names></name></person-group><article-title>Shape-mediated biological effects of mesoporous silica nanoparticles</article-title><source><italic>Journal of Biomedical Nanotechnology</italic></source><year>2014</year><volume>10</volume><issue>10</issue><fpage>2508</fpage><lpage>2538</lpage><pub-id pub-id-type="doi">10.1166/jbn.2014.1940</pub-id><pub-id pub-id-type="pmid">25992407</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>M.</given-names></name><name><surname>Zhao</surname><given-names>J. X.</given-names></name></person-group><article-title>Recent development of silica nanoparticles as delivery vectors for cancer imaging and therapy</article-title><source><italic>Nanomedicine: Nanotechnology, Biology, and Medicine</italic></source><year>2014</year><volume>10</volume><issue>2</issue><fpage>297</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1016/j.nano.2013.08.008</pub-id><pub-id pub-id-type="other">2-s2.0-84895068605</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milgroom</surname><given-names>A.</given-names></name><name><surname>Intrator</surname><given-names>M.</given-names></name><name><surname>Madhavan</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Mesoporous silica nanoparticles as a breast-cancer targeting ultrasound contrast agent</article-title><source><italic>Colloids and Surfaces B: Biointerfaces</italic></source><year>2014</year><volume>116</volume><fpage>652</fpage><lpage>657</lpage><pub-id pub-id-type="doi">10.1016/j.colsurfb.2013.10.038</pub-id><pub-id pub-id-type="other">2-s2.0-84898807916</pub-id><pub-id pub-id-type="pmid">24269054</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>P.</given-names></name><name><surname>Kong</surname><given-names>J.</given-names></name></person-group><article-title>Doxorubicin-tethered fluorescent silica nanoparticles for pH-responsive anticancer drug delivery</article-title><source><italic>Talanta</italic></source><year>2015</year><volume>134</volume><fpage>501</fpage><lpage>507</lpage><pub-id pub-id-type="doi">10.1016/j.talanta.2014.09.041</pub-id><pub-id pub-id-type="other">2-s2.0-84919492142</pub-id><pub-id pub-id-type="pmid">25618700</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreani</surname><given-names>T.</given-names></name><name><surname>Kiill</surname><given-names>C. P.</given-names></name><name><surname>de Souza</surname><given-names>A. L. R.</given-names></name><etal/></person-group><article-title>Surface engineering of silica nanoparticles for oral insulin delivery: characterization and cell toxicity studies</article-title><source><italic>Colloids and Surfaces B: Biointerfaces</italic></source><year>2014</year><volume>123</volume><fpage>916</fpage><lpage>923</lpage><pub-id pub-id-type="doi">10.1016/j.colsurfb.2014.10.047</pub-id><pub-id pub-id-type="other">2-s2.0-84915737304</pub-id><pub-id pub-id-type="pmid">25466464</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koch</surname><given-names>F.</given-names></name><name><surname>M&#x000f6;ller</surname><given-names>A.-M.</given-names></name><name><surname>Frenz</surname><given-names>M.</given-names></name><name><surname>Pieles</surname><given-names>U.</given-names></name><name><surname>Kuehni-Boghenbor</surname><given-names>K.</given-names></name><name><surname>Mevissen</surname><given-names>M.</given-names></name></person-group><article-title>An in vitro toxicity evaluation of gold-, PLLA- and PCL-coated silica nanoparticles in neuronal cells for nanoparticle-assisted laser-tissue soldering</article-title><source><italic>Toxicology in Vitro</italic></source><year>2014</year><volume>28</volume><issue>5</issue><fpage>990</fpage><lpage>998</lpage><pub-id pub-id-type="doi">10.1016/j.tiv.2014.04.010</pub-id><pub-id pub-id-type="other">2-s2.0-84900801634</pub-id><pub-id pub-id-type="pmid">24768613</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>M.-S.</given-names></name><name><surname>Lee</surname><given-names>D.</given-names></name><etal/></person-group><article-title>The comparative immunotoxicity of mesoporous silica nanoparticles and colloidal silica nanoparticles in mice</article-title><source><italic>International Journal of Nanomedicine</italic></source><year>2013</year><volume>8</volume><fpage>147</fpage><lpage>158</lpage><pub-id pub-id-type="doi">10.2147/IJN.S39534</pub-id><pub-id pub-id-type="other">2-s2.0-84872332027</pub-id><pub-id pub-id-type="pmid">23326190</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>X.</given-names></name><name><surname>Zhao</surname><given-names>N.</given-names></name><name><surname>Yan</surname><given-names>P.</given-names></name><name><surname>Hua</surname><given-names>H.</given-names></name><name><surname>Xua</surname><given-names>F.-J.</given-names></name></person-group><article-title>The shape and size effects of polycation functionalized silica nanoparticles on gene transfection</article-title><source><italic>Acta Biomaterialia</italic></source><year>2015</year><volume>11</volume><fpage>381</fpage><lpage>392</lpage><pub-id pub-id-type="doi">10.1016/j.actbio.2014.09.004</pub-id><pub-id pub-id-type="pmid">25219349</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Pokrovskiy</surname><given-names>V. A.</given-names></name><name><surname>Galagan</surname><given-names>N. P.</given-names></name><name><surname>Chuiko</surname><given-names>A. A.</given-names></name></person-group><article-title>Interaction of cells with nanoparticles</article-title><source><italic>Surface Chemistry in Biomedical and Environmental Science</italic></source><year>2006</year><volume>2</volume><publisher-loc>Dordrecht, The Netherlands</publisher-loc><publisher-name>Springer</publisher-name><fpage>277</fpage><lpage>286</lpage><pub-id pub-id-type="doi">10.1007/1-4020-4741-X_24</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korolova</surname><given-names>D. S.</given-names></name><name><surname>Chernyshenko</surname><given-names>T. M.</given-names></name><name><surname>Gornytska</surname><given-names>O. V.</given-names></name><name><surname>Chernyshenko</surname><given-names>V. O.</given-names></name><name><surname>Platonova</surname><given-names>T. N.</given-names></name></person-group><article-title>Meizothrombin preparation and its role in fibrin formation and platelet aggregation</article-title><source><italic>Advances in Bioscience and Biotechnology</italic></source><year>2014</year><volume>5</volume><issue>7</issue><fpage>588</fpage><lpage>595</lpage><pub-id pub-id-type="doi">10.4236/abb.2014.57069</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chernyshenko</surname><given-names>V. O.</given-names></name><name><surname>Korolova</surname><given-names>D. S.</given-names></name><name><surname>Dosenko</surname><given-names>V. &#x00415;.</given-names></name><etal/></person-group><article-title>Calix[4]arene C-145 effects on plasma haemostasis</article-title><source><italic>Pharmaceutica Analytica Acta</italic></source><year>2015</year><volume>6, article 406</volume><pub-id pub-id-type="doi">10.4172/2153-2435.1000406</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lottenberg</surname><given-names>R.</given-names></name><name><surname>Christensen</surname><given-names>U.</given-names></name><name><surname>Jackson</surname><given-names>C. M.</given-names></name><name><surname>Coleman</surname><given-names>P. L.</given-names></name></person-group><article-title>Assay of coagulation proteases using peptide chromogenic and fluorogenic substrates</article-title><source><italic>Methods in Enzymology</italic></source><year>1981</year><volume>80</volume><fpage>341</fpage><lpage>361</lpage><pub-id pub-id-type="doi">10.1016/S0076-6879(81)80030-4</pub-id><pub-id pub-id-type="pmid">6210826</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castro</surname><given-names>H. C.</given-names></name><name><surname>Zingali</surname><given-names>R. B.</given-names></name><name><surname>Albuquerque</surname><given-names>M. G.</given-names></name><name><surname>Pujol-Luz</surname><given-names>M.</given-names></name><name><surname>Rodrigues</surname><given-names>C. R.</given-names></name></person-group><article-title>Snake venom thrombin-like enzymes: from reptilase to now</article-title><source><italic>Cellular and Molecular Life Sciences</italic></source><year>2004</year><volume>61</volume><issue>7-8</issue><fpage>843</fpage><lpage>856</lpage><pub-id pub-id-type="doi">10.1007/s00018-003-3325-z</pub-id><pub-id pub-id-type="other">2-s2.0-2442621031</pub-id><pub-id pub-id-type="pmid">15095007</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cattaneo</surname><given-names>M.</given-names></name><name><surname>Cerletti</surname><given-names>C.</given-names></name><name><surname>Harrison</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the platelet physiology subcommittee of SSC/ISTH</article-title><source><italic>Journal of Thrombosis and Haemostasis</italic></source><year>2013</year><volume>11</volume><issue>6</issue><fpage>1183</fpage><lpage>1189</lpage><pub-id pub-id-type="doi">10.1111/jth.12231</pub-id><pub-id pub-id-type="other">2-s2.0-84883825698</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konokhova</surname><given-names>A. I.</given-names></name><name><surname>Yurkin</surname><given-names>M. A.</given-names></name><name><surname>Moskalensky</surname><given-names>A. E.</given-names></name><etal/></person-group><article-title>Light-scattering flow cytometry for identification and characterization of blood microparticles</article-title><source><italic>Journal of Biomedical Optics</italic></source><year>2012</year><volume>17</volume><issue>5</issue><pub-id pub-id-type="publisher-id">057006</pub-id><pub-id pub-id-type="doi">10.1117/1.jbo.17.5.057006</pub-id><pub-id pub-id-type="other">2-s2.0-84866792422</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marsh</surname><given-names>N.</given-names></name><name><surname>Williams</surname><given-names>V.</given-names></name></person-group><article-title>Practical applications of snake venom toxins in haemostasis</article-title><source><italic>Toxicon</italic></source><year>2005</year><volume>45</volume><issue>8</issue><fpage>1171</fpage><lpage>1181</lpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2005.02.016</pub-id><pub-id pub-id-type="other">2-s2.0-19544362198</pub-id><pub-id pub-id-type="pmid">15922782</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>S. P.</given-names></name></person-group><article-title>The growing complexity of platelet aggregation</article-title><source><italic>Blood</italic></source><year>2007</year><volume>109</volume><issue>12</issue><fpage>5087</fpage><lpage>5095</lpage><pub-id pub-id-type="doi">10.1182/blood-2006-12-027698</pub-id><pub-id pub-id-type="other">2-s2.0-34250007429</pub-id><pub-id pub-id-type="pmid">17311994</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kondo</surname><given-names>A.</given-names></name><name><surname>Oku</surname><given-names>S.</given-names></name><name><surname>Higashitani</surname><given-names>K.</given-names></name></person-group><article-title>Structural changes in protein molecules adsorbed on ultrafine silica particles</article-title><source><italic>Journal of Colloid and Interface Science</italic></source><year>1991</year><volume>143</volume><issue>1</issue><fpage>214</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1016/0021-9797(91)90454-g</pub-id><pub-id pub-id-type="other">2-s2.0-58149208446</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lord</surname><given-names>M. S.</given-names></name><name><surname>Cousins</surname><given-names>B. G.</given-names></name><name><surname>Doherty</surname><given-names>P. J.</given-names></name><etal/></person-group><article-title>The effect of silica nanoparticulate coatings on serum protein adsorption and cellular response</article-title><source><italic>Biomaterials</italic></source><year>2006</year><volume>27</volume><issue>28</issue><fpage>4856</fpage><lpage>4862</lpage><pub-id pub-id-type="doi">10.1016/j.biomaterials.2006.05.037</pub-id><pub-id pub-id-type="other">2-s2.0-33744978387</pub-id><pub-id pub-id-type="pmid">16757021</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>C. J.</given-names></name><name><surname>Clegg</surname><given-names>R. E.</given-names></name><name><surname>Leavesley</surname><given-names>D. I.</given-names></name><name><surname>Pearcy</surname><given-names>M. J.</given-names></name></person-group><article-title>Mediation of biomaterial-cell interactions by adsorbed proteins: a review</article-title><source><italic>Tissue Engineering</italic></source><year>2005</year><volume>11</volume><issue>1-2</issue><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1089/ten.2005.11.1</pub-id><pub-id pub-id-type="other">2-s2.0-17144422105</pub-id><pub-id pub-id-type="pmid">15738657</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corbalan</surname><given-names>J. J.</given-names></name><name><surname>Medina</surname><given-names>C.</given-names></name><name><surname>Jacoby</surname><given-names>A.</given-names></name><name><surname>Malinski</surname><given-names>T.</given-names></name><name><surname>Radomski</surname><given-names>M. W.</given-names></name></person-group><article-title>Amorphous silica nanoparticles aggregate human platelets: potential implications for vascular homeostasis</article-title><source><italic>International Journal of Nanomedicine</italic></source><year>2012</year><volume>7</volume><fpage>631</fpage><lpage>639</lpage><pub-id pub-id-type="doi">10.2147/ijn.s28293</pub-id><pub-id pub-id-type="other">2-s2.0-84865616187</pub-id><pub-id pub-id-type="pmid">22334785</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Englehart</surname><given-names>M. S.</given-names></name><name><surname>Cho</surname><given-names>S. D.</given-names></name><name><surname>Tieu</surname><given-names>B. H.</given-names></name><etal/></person-group><article-title>A novel highly porous silica and chitosan-based hemostatic dressing is superior to HemCon and gauze sponges</article-title><source><italic>The Journal of Trauma</italic></source><year>2008</year><volume>65</volume><issue>4</issue><fpage>884</fpage><lpage>892</lpage><pub-id pub-id-type="doi">10.1097/ta.0b013e318187800b</pub-id><pub-id pub-id-type="other">2-s2.0-56149126937</pub-id><pub-id pub-id-type="pmid">18849807</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sambasivan</surname><given-names>C. N.</given-names></name><name><surname>Cho</surname><given-names>S. D.</given-names></name><name><surname>Zink</surname><given-names>K. A.</given-names></name><name><surname>Differding</surname><given-names>J. A.</given-names></name><name><surname>Schreiber</surname><given-names>M. A.</given-names></name></person-group><article-title>A highly porous silica and chitosan-based hemostatic dressing is superior in controlling hemorrhage in a severe groin injury model in swine</article-title><source><italic>The American Journal of Surgery</italic></source><year>2009</year><volume>197</volume><issue>5</issue><fpage>576</fpage><lpage>580</lpage><pub-id pub-id-type="doi">10.1016/j.amjsurg.2008.12.011</pub-id><pub-id pub-id-type="other">2-s2.0-64749105166</pub-id><pub-id pub-id-type="pmid">19393351</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chernyshenko</surname><given-names>T. M.</given-names></name><name><surname>Gryshchuk</surname><given-names>V. I.</given-names></name><name><surname>Galagan</surname><given-names>N. P.</given-names></name><etal/></person-group><article-title>Action of high-dispersed silica on blood coagulation factors activation</article-title><source><italic>Biotechnologia Acta</italic></source><year>2013</year><volume>6</volume><issue>1</issue><fpage>81</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.15407/biotech6.01.081</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>T.</given-names></name><name><surname>Yoshioka</surname><given-names>Y.</given-names></name><name><surname>Tochigi</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Intranasal exposure to amorphous nanosilica particles could activate intrinsic coagulation cascade and platelets in mice</article-title><source><italic>Particle and Fibre Toxicology</italic></source><year>2013</year><volume>10, article 41</volume><pub-id pub-id-type="doi">10.1186/1743-8977-10-41</pub-id><pub-id pub-id-type="other">2-s2.0-84882969218</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kushida</surname><given-names>T.</given-names></name><name><surname>Saha</surname><given-names>K.</given-names></name><name><surname>Subramani</surname><given-names>C.</given-names></name><name><surname>Nandwana</surname><given-names>V.</given-names></name><name><surname>Rotello</surname><given-names>V. M.</given-names></name></person-group><article-title>Effect of nano-scale curvature on the intrinsic blood coagulation system</article-title><source><italic>Nanoscale</italic></source><year>2014</year><volume>6</volume><issue>23</issue><fpage>14484</fpage><lpage>14487</lpage><pub-id pub-id-type="doi">10.1039/c4nr04128c</pub-id><pub-id pub-id-type="other">2-s2.0-84908873226</pub-id><pub-id pub-id-type="pmid">25341004</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Sun</surname><given-names>J.</given-names></name></person-group><article-title>Time-course effects of intravenously administrated silica nanoparticles on blood coagulation and endothelial function in rats</article-title><source><italic>Journal of Nanoscience and Nanotechnology</italic></source><year>2013</year><volume>13</volume><issue>1</issue><fpage>222</fpage><lpage>228</lpage><pub-id pub-id-type="doi">10.1166/jnn.2013.6910</pub-id><pub-id pub-id-type="other">2-s2.0-84876228283</pub-id><pub-id pub-id-type="pmid">23646720</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Activated partial thromboplastin time (APTT) of human blood plasma (a) and prothrombin time (PT) of human blood plasma (b) in the presence of 0,2&#x02009;mg/mL and 0,4&#x02009;mg/mL of SiNPs.</p></caption><graphic xlink:href="BRI2016-2959414.001"/></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>(a) Effect of SiNPs (0,4&#x02009;mg/mL) on factor X activation by RVV. (b) Effect of SiNPs (0,4&#x02009;mg/mL) on prothrombin activation by ecamulin. (1) Control; (2) sample with SiNPs.</p></caption><graphic xlink:href="BRI2016-2959414.002"/></fig><fig id="fig3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Platelet aggregation in platelet rich plasma (PRP) induced by 2.5 <italic>&#x003bc;</italic>M ADP in the presence of 0.001&#x02009;mg/mL and 0.01&#x02009;mg/mL of SiNPs. (1) Aggregation of control PRP; (2) aggregation of PRP in the presence of 0.001&#x02009;mg/mL of SiNPs; (3) aggregation of PRP in the presence of 0.01&#x02009;mg/mL of SiNPs.</p></caption><graphic xlink:href="BRI2016-2959414.003"/></fig><fig id="fig4" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Flow cytometry of human platelet rich plasma incubated with 0.01&#x02009;mg/mL and 0.001&#x02009;mg/mL of silica nanoparticles (SiNPs). Distribution of platelets according to their shape and granulation. SS LOG, parameter of platelets granulation: FS LOG, parameter of platelets shape. (a) Resting platelets incubated with equal volume of TBS as a control; (b) resting platelets incubated with 0.001&#x02009;mg/mL of SiNPs (silica nanoparticles) during 5&#x02009;min; (c) platelets activated by thrombin (0,125&#x02009;NIH/mL) for 2&#x02009;min; (d) platelets activated by thrombin, preincubated with 0.01&#x02009;mg/mL of SiNPs during 5&#x02009;min.</p></caption><graphic xlink:href="BRI2016-2959414.004"/></fig></floats-group></article>